Revisiting diagnostic criteria for myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Borderline cases without anemia exist.
Peng LiNahid ShahmarvandDavid LynchJason R GotlibJason D MerkerJames L ZehnderTracy I GeorgeRobert S OhgamiPublished in: International journal of laboratory hematology (2019)
Given these findings, the requirement of refractory anemia as a diagnostic criterion for MDS/MPN-RS-T should be re-evaluated. Removal of refractory anemia as a diagnostic criterion would incorporate current borderline cases and extend the spectrum of this disorder.